NCT05886283

Brief Summary

Purpose: The aim of this study was to evaluate corneal endothelial cell density and morphology, central corneal thickness, and best visual acuity using US phacoemulsification or Nanosecond laser technique. Setting: Department of ophthalmology, Nabeul, Tunisia. Design: Prospective cohort study. Methods: The study included eyes with nuclear cataract density grade 1, 2, 3, or 4 according to LOCS III, divided into two groups; Group 1 had conventional US, and group 2 had nanosecond laser. The Endothelial Cell Density (ECD), coefficient of variation (CoV) in cell size, percentage of hexagonal cells, central corneal thickness and best visual acuity were evaluated over 24 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2017

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2020

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

April 12, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 2, 2023

Completed
Last Updated

June 5, 2023

Status Verified

June 1, 2023

Enrollment Period

3.3 years

First QC Date

April 12, 2023

Last Update Submit

June 1, 2023

Conditions

Keywords

cataract surgeryphacoemulsificationNanosecond laserendothelial cells density

Outcome Measures

Primary Outcomes (7)

  • Endothelial cell density (ECD)

    The endothelium of the central cornea was examined using a non-contact specular microscope (SM) (TOMEY CORP EM-4000).

    2 years

  • Percentage of endothelial cell loss (ECL)

    ECL was evaluated using a non-contact specular microscope (SM) (TOMEY CORP EM-4000).

    2 years

  • Mean percentage of hexagonal cells

    The mean percentage of hexagonal cells was evaluated using a non-contact specular microscope (SM) (TOMEY CORP EM-4000).

    2 years

  • Mean coefficient of variance (CoV)

    CoV was evaluated using a non-contact specular microscope (SM) (TOMEY CORP EM-4000).

    2 years

  • Central corneal thickness (CCT)

    CCT was evaluated using a non-contact specular microscope (SM) (TOMEY CORP EM-4000).

    2 years

  • Uncorrected visual acuity (UVA)

    UVA was evaluated at 1 day post-operatively

    2 years

  • Best corrected visual acuity (BCVA)

    2 years

Study Arms (2)

ultrasound phaco groupe

ACTIVE COMPARATOR

this group had US PHACO using the phaco-chop technique (Stellaris PC: Bausch + Lomb®)

Procedure: phacoemulsificationProcedure: utrasound phacoemulsification

nanolaser phaco group

ACTIVE COMPARATOR

this group underwent an NL PHACO (Cetus A.R.C. Laser system®)

Procedure: phacoemulsificationProcedure: nanolaser phacoemulsification

Interventions

we started with a clear corneal incision of 2.2 mm at 9 o'clock and a port incision of 1 at 2 o'clock. Continuous Circular Capsulorhexis of 6 mm was performed under the same ophthalmic viscosurgical device. A hydro dissection was performed, then followed by phacoemulsification. the Nucleus has been treated using 2 different techniques After bimanual infusion/aspiration cortex removal and Visco expansion of the capsular bag, a hydrophobic single-piece: AcrySof acrylic IOL was implanted.

nanolaser phaco groupultrasound phaco groupe

US group:The nucleus was held with the phaco tip at a high vacuum. The phaco choppe was drawn towards the phaco tip to cleave it by a manual separation between the two instruments. The fragments were then aspirated with phaco power. The standard parameters used during phacoemulsification were a vacuum level of 500 mmHg, pressurized irrigation of 90 mmHg, and 40% of phaco power

ultrasound phaco groupe

Laser group: The nucleus was fragmented using the shockwaves emanating from the phaco tip and then aspirated. The phaco chopper was used to accelerate the mechanical fragmentation of the nucleus and minimize the dissipated energy.

nanolaser phaco group

Eligibility Criteria

Age50 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Senile cataract.
  • Preoperative endothelial cell count (ECC) less than 1500 cells/mm2.
  • Pathological alterations of the anterior segment such as corneal opacities, cornea Guttata, uveitis, pseudoexfoliative syndrome, glaucoma, high myopia axil length (≥ 26 mm), or suffering from chronic pathologies that may affect corneal endothelium

You may not qualify if:

  • Conversion from NL PHACO to US PHACO.
  • Surgery was complicated with capsular rent and vitreous loss.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mohamed Taher Maamouri Hospital

Nabeul, 8000, Tunisia

Location

Related Publications (1)

  • Zbiba W, Kharrat M, Sayadi S, Kallel Z, Marzouk G. Qualitative and quantitative endothelium changes after cataract surgery: ultrasound phacoemulsification vs. nanolaser technique. Front Med (Lausanne). 2023 Sep 21;10:1097404. doi: 10.3389/fmed.2023.1097404. eCollection 2023.

MeSH Terms

Interventions

Phacoemulsification

Intervention Hierarchy (Ancestors)

Cataract ExtractionRefractive Surgical ProceduresOphthalmologic Surgical ProceduresSurgical Procedures, OperativeUltrasonic Surgical Procedures

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
the investigator does not know the technique used to operate on the cataract during the follow-up
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A randomized prospective, uncontrolled cohort study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

April 12, 2023

First Posted

June 2, 2023

Study Start

March 1, 2017

Primary Completion

May 31, 2020

Study Completion

December 30, 2020

Last Updated

June 5, 2023

Record last verified: 2023-06

Locations